After a Decade of Progress Against HIV, PrEP Enters a Precarious Era

JAMA 2026

View at publisher
Authors: Kate Schweitzer
DOI: 10.1001/jama.2026.1795
Cited by: 0

Abstract

This Medical News article discusses the success of preexposure prophylaxis (PrEP) in reducing HIV infections in the US and threats from federal funding cuts that could exacerbate barriers to access.

Fields of Study & Subjects

HIV/AIDS Research and Interventions HIV Drug Use Sexual Risk HIV/AIDS drug development and treatment

Publication details

Journal / source
JAMA
Volume
335
Issue
13
Pages
1108–1108
Publication date
13 March 2026
Language
EN